The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small cell lung cancer patients: The NVALT-8 study.
 
Harry J.M. Groen
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Roche/Genentech (Inst)
Research Funding - Lilly (Inst); Roche/Genentech (Inst)
 
Erik van der Heijden
Consulting or Advisory Role - Medi Globe
Speakers' Bureau - MSD Oncology; Pentax Medical Devices
Research Funding - Pentax Medical Devices (Inst)
Travel, Accommodations, Expenses - Medi Globe; MSD; Pentax Medical Devices; Pfizer
 
Theo J Klinkenberg
No Relationships to Disclose
 
Bonne Biesma
No Relationships to Disclose
 
Joachim Aerts
No Relationships to Disclose
 
Ad Verhagen
No Relationships to Disclose
 
Corinne Kloosterziel
No Relationships to Disclose
 
Hans J.M. Smit
No Relationships to Disclose
 
Franz Schramel
No Relationships to Disclose
 
Vincent van der Noort
No Relationships to Disclose
 
Harm van Tinteren
No Relationships to Disclose
 
Egbert F. Smit
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Roche/Genentech (Inst)
 
Anne-Marie C. Dingemans
No Relationships to Disclose